Making Their Move | GenomeWeb

Making Their Move

The pharmacy-benefit managers Medco and CVS Caremark may soon take over the genetic testing business as they did the prescription business, says Technology Review. Medco bought up DNA Direct and CVS now has a larger stake in Generation Health. Tech Review says that Medco is targeting the gaps in physicians' and patients' knowledge — their pharmacists call up, offer a genetic test for the prescribed drug, and help interpret the results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.